Renal tubular dysgenesis associated with in utero exposure to Nimuselide

Pediatric Nephrology

Volumn 21, Issue 2, 2006, Pages 274-276

  Ali, Uma Sankari ^a,c   Khubchandani, Sheila ^b   Andankar, Parmanand ^a   Parekhji, Shashank ^a   Dubhalish, Vishal ^a   Padhye, Bhavna ^a  

^a B J WADIA HOSPITAL FOR CHILDREN   (India)

^b JASLOK HOSPITAL AND RESEARCH CENTRE   (India)

^c NONE   (India)

Author keywords

COX 2 inhibitors; Drug ingestion in pregnancy; Neonatal renal failure; Nimuselide; Renal tubular dysgenesis

Indexed keywords

ALKALI; CREATININE; CYCLOOXYGENASE 2 INHIBITOR; ENALAPRIL; NIFEDIPINE; NIMUSELIDE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE REGULATION; CASE REPORT; CLINICAL FEATURE; CONSERVATIVE TREATMENT; CREATININE BLOOD LEVEL; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; KIDNEY BIOPSY; KIDNEY TUBULE ACIDOSIS; KIDNEY TUBULE DISORDER; KIDNEY TUBULE DYSGENESIS; MALE; METABOLIC ACIDOSIS; PHYSICAL EXAMINATION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; TISSUE SECTION; TREATMENT OUTCOME; URINALYSIS; URINE VOLUME;

ABNORMALITIES, DRUG-INDUCED; CYCLOOXYGENASE INHIBITORS; FEMALE; HUMANS; INFANT, NEWBORN; KIDNEY FAILURE; KIDNEY TUBULES; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SULFONAMIDES;

EID: 30944467987     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-005-2089-0     Document Type: Article

References (11)

1. Peruzzi L, Gianoglio B, Porcellini MG, Coppe R (1999) Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase type 1 selective inhibitor nimuselide as tocolytic. Lancet 354:1615 10.1016/S0140-6736(99)03105-0
2. Balasubramanian J (2000) Nimuselide and neonatal renal failure. Lancet 355:575 10.1016/S0140-6736(05)73223-2
3. Holmes RP, Stone PR (2000) Severe oligohydramnios induced by cyclooxygenase 2 inhibitor nimuselide. Obstet Gynecol 96:810-811 10.1016/ S0029-7844(00)01047-4
4. Dinchuk JE, Car BD, Fochet RJ, Johnston JJ, Jaffe BD, Covington MB, Contel NR, Eng VM, Collins RJ, Czerniak PM (1995) Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378:406-409 10.1038/378406a0
5. Zhang MZ, Wang JL, Chang HF, Harris RC, Mc Kamna JA (1997) COX-2 in rat nephron development. Am J Physiology 273:F994-F1002
6. Allanson JE, Hunter AGW, Mettler GS, Jimenez C (1992) Renal tubular dysgenesis: Not an uncommon autosomal recessive syndrome. A review. Am J Med Genet 43:811-814 10.1002/ajmg.1320430512
7. Pryde PG, Sedman AB, Nugent CE, Barr M Jr (1993) Angiotensin converting enzyme inhibitor fetopathy. J Am Soc Nephrol 3:1575-1582 8507813
8. Kaplan BS, Restaino I, Raval DS, Gottlieb RB, Bernstein J (1994) Renal failure in the neonate associated with in utero exposure to non-steroidal anti-inflammatory drugs. Pediatr Nephrol 8:700-704 10.1007/ BF00869093
9. Voyer LE, Drut R, Mendez JH (1994) Fetal renal maldevelopment with oligohydramnios following maternal use of piroxicam. Pediatr Nephrol 8:592-594 10.1007/BF00858136
10. Benini D, Fanos V, Cuzzolin L, Tato L (2004) In utero exposure to nonsteroidal anti-inflammatory drugs: Neonatal renal failure. Pediatr Nephrol 19:232-234 10.1007/s00467-003-1338-3
11. Oberg KC, Pestaner JP Bielamosicz L, Hawkins EP (1999) Renal tubular dysgenesis in twin-twin transfusion syndrome. Pediatr Dev Pathol 2:25-32 10.1007/s100249900086